BIT 0.00% 3.3¢ biotron limited

a cure for hep c, aids, the flu and dengue..., page-91

  1. 13,013 Posts.
    lightbulb Created with Sketch. 99
    Should the current HCV trial prove successful, I think it will be important for holders to exercise their options early so that the company can move straight on with the HIV trial.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.